Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 3.81
- Piotroski Score 5.00
- Grade Outperform
- Symbol (ASTH)
- Company Astrana Health, Inc.
- Price $42.16
- Changes Percentage (0.11%)
- Change $0.05
- Day Low $41.99
- Day High $42.85
- Year High $63.20
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/20/2025
- Fiscal Year End N/A
- Average Stock Price Target $67.00
- High Stock Price Target $70.00
- Low Stock Price Target $48.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.00
- Trailing P/E Ratio N/A
- Forward P/E Ratio N/A
- P/E Growth N/A
- Net Income $60.72 M
Income Statement
Quarterly
Annual
Latest News of ASTH
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Popular asthma drug may be linked to serious mental health problems
Recent findings show that the asthma drug Singulair, manufactured by Merck & Co, may be linked to serious mental health issues. The FDA added a black box warning in 2020 after reports of neuropsychiat...
By New York Post | 19 hours ago -
Exclusive-US FDA finds widely used asthma drug impacts the brain
Recent research suggests a link between the asthma drug Singulair and mental health issues. FDA reports show neuropsychiatric episodes, leading to a "black box" warning in 2020. Further studies are ne...
By Yahoo! Finance | 1 day ago -
Astrana Health, Inc. (ASTH) Stock Price, News, Quote & History - Yahoo Finance
Astrana Health has finalized a deal to acquire specific businesses and assets of Prospect Health System, a move that will strengthen its position as a provider-centric healthcare company delivering qu...
By Yahoo! Finance | 2 weeks ago
